Brain Cancer: Epidemiology Forecast to 2027

Brain Cancer: Epidemiology Forecast to 2027

  • October 2018 •
  • 32 pages •
  • Report ID: 5637670 •
  • Format: PDF
Brain Cancer: Epidemiology Forecast to 2027

Summary
Epidemiologists forecast that the diagnosed incident cases of brain cancer will increase from 119,717 cases in 2017 to 151,067 cases in 2027, at an Annual Growth Rate (AGR) of 2.62% in the 8MM (US, France, Germany, Italy, Spain, UK, Japan, and urban China). Urban China will have the highest number of diagnosed incident cases of brain cancer among the 8MM throughout the forecast period. The five-year diagnosed prevalent cases of brain cancer are also expected to increase from 220,839 cases in 2017 to 262,409 cases in 2027, at an AGR of 1.88%.

Primary brain cancer is defined as a malignant neoplasm that originates in the central nervous system (CNS), which consists of the brain and spinal cord, including the brain stem.The American Brain Tumor Association (ABTA) reports that there are over 120 different types of malignant and benign brain tumors (ABTA, 2014).

The type and severity of a brain tumor is defined by the cells from which the tumor originated, as well as by the proliferative potential of the abnormal growth.Only malignant tumors are designated as cancer.

Primary brain tumors are those that start in the brain and may, in time, migrate elsewhere in the body, while metastatic brain tumors are those that start elsewhere in the body and migrate to the brain or other parts of the CNS.

"Brain Cancer: Epidemiology Forecast to 2027". report provides an overview of the risk factors, comorbidities, and the global and historical trends for primary brain cancer in the eight major markets (8MM) (US, France, Germany, Italy, Spain, UK, Japan, and urban China). It includes a 10-year epidemiological forecast for the diagnosed incident cases and the five-year diagnosed prevalent cases of brain cancer.

Additionally, it includes a forecast for the diagnosed incident cases of brain cancer segmented by type (glioblastoma, meningioma, ependymoma, oligodendroglioma, and CNS lymphoma). This forecast for brain cancer includes only primary malignant brain tumors originating in the CNS (ICD-10 codes C70-C72).

Scope
- The brain cancer Epidemiology Forecast Report provides an overview of the risk factors and global trends brain cancer in the eight major markets (8MM: US, France, Germany, Italy, Spain, UK, Japan, and urban China).
- This report also includes a 10-year epidemiological forecast for the following segmentations in all ages across the 8MM: diagnosed incident cases of brain cancer; five-year diagnosed prevalent cases; diagnosed incident cases of brain cancer type; and diagnosed incident cases of brain cancer with associated biomarkers.
- The brain cancer epidemiology forecast report is written and developed by Masters- and PhD-level epidemiologists.
- The Epidemiology Forecast Report is in-depth, high quality, transparent, and market-driven, providing expert analysis of disease trends in the 8MM.

Reasons to buy
The Brain Cancer Epidemiology Forecast report will allow you to -

- Develop business strategies by understanding the trends shaping and driving the global brain cancer market.
- Quantify patient populations in the global brain cancer market to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for brain cancer therapeutics in each of the markets covered.
- Understand magnitude of brain cancer population by associated biomarkers.
Loading...

We are very sorry, but an error occurred.
Please contact support@reportbuyer.com if the problem remains.